MENU ABOUT US MAKE A DONATION
The Epoch Times
Login
SEARCH
CLOSE
Help Center subscribe newsletter Newsstands Epoch Shop Gift
  • TOP NEWS
  • SPECIAL SERIES
  • SPECIAL COVERAGE
  • LATEST ARTICLES
  • US
    • US News
    • US Features
    • US Politics
    • US Crime News
    • New York
    • San Francisco
    • Los Angeles
  • Opinion
    • Thinking About China
    • Viewpoints
    • Unbridled Evil: The Corrupt Reign of Jiang Zemin in China
    • The Reader’s Turn
  • China News
    • US-China Relations
    • Chinese Regime
    • Business & Economy
    • Chinese Culture
    • China Human Rights
    • Social Issues
    • Organ Harvesting in China
  • World News
    • Africa News
    • Americas
    • Asia & Pacific
    • Canada
    • Europe
    • UK News
    • Australia News
    • International
    • Middle East
  • Business & Markets
    • Companies
    • Economy
    • Markets
    • Real Estate
    • Gold and Commodities
  • ARTS & CULTURE
    • Fine Arts & Craftsmanship
    • Performing Arts
    • Books
    • Traditional Culture
    • Shen Yun Special Coverage
    • Film & TV
  • Science
    • News
    • Space
    • Environment
  • Tech
    • Tech News
    • Tech Products & Reviews
    • Social Media
  • Sports
  • Videos
    • American Thought Leaders
    • China Insider
    • Crossroads
  • Bright
    • Lifestyle
    • Inspired
    • Family & Education
    • Personal Finance
    • American Essence
  • Entertainment
    • Film & TV
    • Entertainment News
  • Health
    • Experts
    • Conditions
    • Life & Wellness
  • Special Topics
    • Battlefields
SEARCH
  • EpochTV
  • US
  • US Politics
  • Opinion
  • World News
  • China
  • Hong Kong
  • Health
  • Bright
  • Arts
  • Falun Gong
  • Premium
  • Markets
  • Games
  • Livestream
  • More

drugmaker

  • Drugmaker Amgen Lays Off 300 US Employees
    Drugmaker Amgen Lays Off 300 US Employees
    Drugmaker Amgen Inc. said on Monday that it let go about 300 U.S. employees or about 1.2 percent of its total workforce, citing recent organizational changes to its commercial team. ...
    January 30, 2023BY Reuters
  • Endo Files for Bankruptcy as US Opioid Litigation Drags
    Endo Files for Bankruptcy as US Opioid Litigation Drags
    Endo International Plc. filed for bankruptcy on Tuesday after reaching a $6 billion deal with some of its ...
    August 17, 2022BY Reuters
  • Japan’s Shionogi Seeks Approval for COVID-19 Pill
    Japan’s Shionogi Seeks Approval for COVID-19 Pill
    TOKYO—Drugmaker Shionogi & Co. Ltd. has applied for approval to make and sell its oral COVID-19 treatment in ...
    February 26, 2022BY Reuters
  • Drugmaker Teva Fueled Opioid Addiction in New York, Jury Finds
    Drugmaker Teva Fueled Opioid Addiction in New York, Jury Finds
    NEW YORK—Teva Pharmaceutical Industries Ltd fueled opioid addiction in New York state, a jury found on Thursday, a ...
    January 27, 2022BY Reuters
  • Drugmaker Endo Signs $65 Million Opioid Settlement With Florida
    Drugmaker Endo Signs $65 Million Opioid Settlement With Florida
    Drugmaker Endo International plc said on Tuesday it had agreed to pay up to $65 million to resolve ...
    January 18, 2022BY Reuters
  • Biogen Slumps After Medicare’s Restrictive Decision on Alzheimer’s Drug
    Biogen Slumps After Medicare’s Restrictive Decision on Alzheimer’s Drug
    Shares of Biogen Inc fell nearly 10 percent on Wednesday after the U.S. government announced limited coverage of ...
    January 13, 2022BY Reuters
  • Jury Finds Drugmaker Teva Fueled Opioid Addiction in New York
    Jury Finds Drugmaker Teva Fueled Opioid Addiction in New York
    NEW YORK—Teva Pharmaceutical Industries Ltd fueled opioid addiction in New York state, a jury found on Thursday, a ...
    December 30, 2021BY Reuters
  • AstraZeneca Buys Rare Disease Drugmaker Caelum in Potential $500 Million Deal
    AstraZeneca Buys Rare Disease Drugmaker Caelum in Potential $500 Million Deal
    AstraZeneca will take full control of Caelum Biosciences in a deal worth up to $500 million, the drugmaker ...
    September 29, 2021BY Reuters
  • EU Signs Deal With GSK for Supply of Potential COVID-19 Drug
    EU Signs Deal With GSK for Supply of Potential COVID-19 Drug
    BRUSSELS—The European Union has signed a contract with GlaxoSmithKline (GSK) for the supply of up to 220,000 treatments ...
    July 28, 2021BY Reuters
  • Roche Looking for New Place to Test COVID-19 Pill After Cases Plummet in UK
    Roche Looking for New Place to Test COVID-19 Pill After Cases Plummet in UK
    ZURICH—Roche is looking for another location to carry out trials of its pill to fight COVID-19, after plummeting ...
    April 21, 2021BY Reuters
  • EU Warns It Could Block Vaccine Exports, Wields Legal Threat at Drugmakers
    EU Warns It Could Block Vaccine Exports, Wields Legal Threat at Drugmakers
    BRUSSELS—Europe's fight to secure COVID-19 vaccine supplies intensified on Thursday when the European Union warned drug companies such ...
    January 28, 2021BY Reuters
  • Judge Rules Drugmaker Helped Fuel Opioid Epidemic, Orders $572M Payment
    Judge Rules Drugmaker Helped Fuel Opioid Epidemic, Orders $572M Payment
    NORMAN, Okla.—An Oklahoma judge on Aug. 26 found that Johnson & Johnson and its subsidiaries helped fuel the ...
    August 26, 2019BY The Associated Press
  • Allergan’s Bold Patent Move Could Transform Pharma Landscape
    Allergan’s Bold Patent Move Could Transform Pharma Landscape
    Pharmaceutical giant Allergan struck a bold and unusual deal to protect its patents on a lucrative eye drug ...
    November 11, 2017BY Fan Yu
  • Drugmaker Lilly’s 2016 Forecast Misses Street Expectations
    Drugmaker Lilly’s 2016 Forecast Misses Street Expectations
    Eli Lilly has dropped a lower-than-expected 2016 forecast on Wall Street after wrapping up a year in which ...
    January 5, 2016BY The Associated Press
TOP NEWS
  • DOJ Says Agencies Should Prioritize English Over Other Languages
    NEW By Jack Phillips
    DOJ Says Agencies Should Prioritize English Over Other Languages
  • Kremlin Says Europe Must Show Readiness to Contribute to Peace Process Before Joining Talks
    NEW By Victoria Friedman
    Kremlin Says Europe Must Show Readiness to Contribute to Peace Process Before Joining Talks
  • New White House Chief of Staff Imposes Restrictions on Meeting With Lobbyists
    2hr By Zachary Stieber
    New White House Chief of Staff Imposes Restrictions on Meeting With Lobbyists
  • Microsoft Outlook Emails Approaching Normal Levels After Outage, Company Says
    2hr By Jack Phillips
    Microsoft Outlook Emails Approaching Normal Levels After Outage, Company Says
  • Trump-Ordered Vaccine Safety Report Delayed Past Deadline
    2hr By Zachary Stieber
    Trump-Ordered Vaccine Safety Report Delayed Past Deadline
  • Global Oil Market Shows First Signs of Rebalancing as Gulf Exports Recover: IEA
    3hr By Evgenia Filimianova
    Global Oil Market Shows First Signs of Rebalancing as Gulf Exports Recover: IEA
  • Alleged Chinese Spy Alice Huang Linked to Huawei Data Center: Report
    4hr By Frank Fang
    Alleged Chinese Spy Alice Huang Linked to Huawei Data Center: Report
  • Bessent Blames Commerce Department for Failure to Blacklist Megaspeed
    4hr By Andrew Moran
    Bessent Blames Commerce Department for Failure to Blacklist Megaspeed
  • US Denies Iran’s Claim It Destroyed Radar in Bahrain
    4hr By Evgenia Filimianova
    US Denies Iran’s Claim It Destroyed Radar in Bahrain
  • IRS Collected Over $5.5 Trillion in Federal Taxes in 2026
    4hr By Naveen Athrappully
    IRS Collected Over $5.5 Trillion in Federal Taxes in 2026
The Epoch Times
Copyright © 2000 - 2026 The Epoch Times Association Inc. All Rights Reserved.
Back Top